Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HealthBio Therapeutics is a clinical-stage biotechnology company focused on the discovery and development of innovative treatments for metabolic disorders, such as obesity and type 2 diabetes. The company utilizes a proprietary technology platform to create long-acting multi-agonist peptides, including dual GLP-1/GIP and triple GLP-1/GIP/Glucagon receptor agonists. These candidates are designed to optimize metabolic health by improving weight loss efficacy and glucose regulation while maintaining a favorable safety profile. With a leadership team experienced in metabolic drug development, HealthBio aims to address the global epidemic of obesity through next-generation biologics. The company maintains operations in both the United States and China to leverage global expertise and markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HealthBio Therapeutics.